Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  Jianan Wang,et al.  Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration , 2022, Journal of clinical laboratory analysis.

[3]  Wenbing Yang,et al.  Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer , 2022, Experimental biology and medicine.

[4]  Ted E. Natoli,et al.  A metastasis map of human cancer cell lines , 2020, Nature.

[5]  Sheng Wang,et al.  TGFβ2 is a prognostic‐related biomarker and correlated with immune infiltrates in gastric cancer , 2020, Journal of cellular and molecular medicine.

[6]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[7]  Li Feng,et al.  Long noncoding RNA VCAN‐AS1 contributes to the progression of gastric cancer via regulating p53 expression , 2020, Journal of cellular physiology.

[8]  Miaozun Zhang,et al.  INHBA is a prognostic predictor for patients with colon adenocarcinoma , 2020, BMC Cancer.

[9]  A. Javadmanesh,et al.  Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor , 2020, Scientific Reports.

[10]  Jie Liu,et al.  Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer , 2020, Aging.

[11]  Wei Chen,et al.  Identification of crucial genes and pathways associated with colorectal cancer by bioinformatics analysis , 2020, Oncology letters.

[12]  Xiaoqing Wu,et al.  circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer , 2019, Molecular Cancer.

[13]  T. Fang,et al.  Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation , 2019, Disease markers.

[14]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[15]  Lan Zhang,et al.  LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis , 2019, Gastric Cancer.

[16]  Zhenggang Zhu,et al.  A self-enforcing HOXA11/Stat3 feedback loop promotes stemness properties and peritoneal metastasis in gastric cancer cells , 2019, Theranostics.

[17]  Bo Liu,et al.  INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF‐β signaling pathway , 2019, Journal of cellular physiology.

[18]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[19]  Yingxia Li,et al.  E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma. , 2019, Life sciences.

[20]  Jana Jeschke,et al.  MEXPRESS update 2019 , 2019, Nucleic Acids Res..

[21]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[22]  Peng Zhang,et al.  Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer. , 2019, Cell reports.

[23]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[24]  Jiong Wu,et al.  Integrated bioinformatics analysis of key genes involved in progress of colon cancer , 2019, Molecular genetics & genomic medicine.

[25]  Abhishek Tyagi,et al.  ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness , 2019, Breast Cancer Research and Treatment.

[26]  S. Thiagalingam,et al.  Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis , 2019, Front. Oncol..

[27]  Lijun Rong,et al.  LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers , 2019, Front. Immunol..

[28]  Y. Kakeji,et al.  PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer , 2018, AntiCancer Research.

[29]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[30]  Jia-Nan Cheng,et al.  Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location , 2018, Front. Immunol..

[31]  T. Zimmers,et al.  The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy , 2019, Journal of cachexia, sarcopenia and muscle.

[32]  Fengling Li,et al.  High expression of INHBA is an adverse prognostic factor for de novo acute myeloid leukemia , 2018, Leukemia & lymphoma.

[33]  H. Débat,et al.  TopA, the Sulfolobus solfataricus topoisomerase III, is a decatenase , 2017, Nucleic acids research.

[34]  Jing Wang,et al.  LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..

[35]  B. Shahmoradi,et al.  Evaluation of trace element concentration in cancerous and non-cancerous tissues of human stomach. , 2017, Chemosphere.

[36]  Prahlad T. Ram,et al.  Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. , 2017, JCI insight.

[37]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[38]  T. Yoshikawa,et al.  Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy. , 2017, In vivo.

[39]  M. Pelizzola,et al.  DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells , 2017, Oncogene.

[40]  Yuanyu Wu,et al.  Progress in the treatment of advanced gastric cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[41]  D. Tenen,et al.  ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. , 2016, Gastroenterology.

[42]  Alex Boussioutas,et al.  Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients , 2016, Oncotarget.

[43]  D. Prabhakaran,et al.  DNA methylation markers for oral pre-cancer progression: A critical review , 2016, Oral oncology.

[44]  Joshua A. Bittker,et al.  Correlating chemical sensitivity and basal gene expression reveals mechanism of action , 2015, Nature chemical biology.

[45]  P. Tan,et al.  Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. , 2015, Gastroenterology.

[46]  A. Koch,et al.  MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data , 2015, BMC Genomics.

[47]  Chien-Feng Li,et al.  INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract , 2015, Journal of surgical oncology.

[48]  P. Papageorgis.  TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis , 2015, Journal of oncology.

[49]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[50]  T. Nishida,et al.  Improving prognosis after surgery for gastric cancer. , 2014, The Lancet. Oncology.

[51]  K. Mimori,et al.  Significance of INHBA expression in human colorectal cancer. , 2013, Oncology reports.

[52]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[53]  L. Wakefield,et al.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.

[54]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[55]  G. Jenster,et al.  Activin A stimulates AKR1C3 expression and growth in human prostate cancer. , 2012, Endocrinology.

[56]  Jun Xia,et al.  Upregulated INHBA expression is associated with poor survival in gastric cancer , 2012, Medical Oncology.

[57]  Khay Guan Yeoh,et al.  A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets , 2012, Gut.

[58]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[59]  Wen-Chi Chou,et al.  An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer , 2010, Nucleic acids research.

[60]  D. Beer,et al.  Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. , 2009, Neoplasia.

[61]  Alessandro Giuliani,et al.  Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. , 2009, European journal of cancer.

[62]  Y. Doki,et al.  Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis , 2008, British Journal of Cancer.

[63]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[64]  W. Vale,et al.  Antagonists of activin signaling: mechanisms and potential biological applications , 2005, Trends in Endocrinology & Metabolism.

[65]  D. Phillips,et al.  Activin A and follistatin in systemic inflammation , 2004, Molecular and Cellular Endocrinology.

[66]  D. Botstein,et al.  Variation in gene expression patterns in human gastric cancers. , 2003, Molecular biology of the cell.

[67]  Jacob D. Jaffe,et al.  Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.

[68]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..